Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026)
Aclarion's (ACON) quarterly Net Income towards Common Stockholders came in at -$2.9 million in Q1 2026, down 39.6% YoY from -$4.7 million in Q1 2025, and down 51.05% on a QoQ basis from -$1.9 million in Q4 2025.
Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Aclarion (ACON) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$2.9 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 39.6% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.0 million (down 20.19% YoY) and the FY2025 annual result came in at -$7.2 million, down 2.66% from the prior year.
- Net Income towards Common Stockholders retreated to -$2.9 million in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$944610.0 in Q4 2022 to a low of -$3.7 million in Q2 2022.
- A 5-year average of -$1.7 million and a median of -$1.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 442.62% — and 2023, when it jumped 60.24%.
- Tracing ACON's Net Income towards Common Stockholders over 5 years: stood at -$944610.0 in 2022, then slumped by 33.95% to -$1.3 million in 2023, then tumbled by 60.99% to -$2.0 million in 2024, then advanced by 7.26% to -$1.9 million in 2025, then plunged by 51.05% to -$2.9 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$2.9 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 84.30 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 69.42 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -17.93 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 43.10 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 40.87 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 24.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -15.74 Mn |
| 10 | Aclarion | 6.06 Mn | 6.06 Mn | 8,297.00 | -2.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.75 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.38 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -998,010.00 |
| Jun 30, 2023 | -1.46 Mn |
| Mar 31, 2023 | -1.18 Mn |
| Dec 31, 2022 | -944,610.00 |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | -3.68 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | -3.24 Mn |